Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Dinesh Chellappan and Kamal Dua.
Connection Strength

13.182
  1. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chem Biol Interact. 2019 Sep 01; 310:108732.
    View in: PubMed
    Score: 0.830
  2. Gene therapy and type 1 diabetes mellitus. Biomed Pharmacother. 2018 Dec; 108:1188-1200.
    View in: PubMed
    Score: 0.789
  3. Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota? Panminerva Med. 2018 09; 60(3):136-137.
    View in: PubMed
    Score: 0.784
  4. Nanogels linked with chitosan: a perspective. Minerva Med. 2018 06; 109(3):254-255.
    View in: PubMed
    Score: 0.770
  5. Current therapies and targets for type 2 diabetes mellitus. Panminerva Med. 2018 Sep; 60(3):117-131.
    View in: PubMed
    Score: 0.765
  6. The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review. Biomed Pharmacother. 2018 Jun; 102:1127-1144.
    View in: PubMed
    Score: 0.762
  7. Immunological axis of curcumin-loaded vesicular drug delivery systems. Future Med Chem. 2018 04 01; 10(8):839-844.
    View in: PubMed
    Score: 0.761
  8. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics. Drug Dev Res. 2021 11; 82(7):880-882.
    View in: PubMed
    Score: 0.240
  9. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci. 2021 Sep 01; 280:119744.
    View in: PubMed
    Score: 0.238
  10. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech. 2021 Jun 08; 22(5):173.
    View in: PubMed
    Score: 0.237
  11. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact. 2021 Aug 01; 344:109497.
    View in: PubMed
    Score: 0.236
  12. Phytochemistry and pharmacological activity of the genus artemisia. Arch Pharm Res. 2021 May; 44(5):439-474.
    View in: PubMed
    Score: 0.235
  13. COVID-19 in underlying COPD Patients. EXCLI J. 2021; 20:248-251.
    View in: PubMed
    Score: 0.232
  14. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209.
    View in: PubMed
    Score: 0.231
  15. Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis. Med Hypotheses. 2020 Nov; 144:110254.
    View in: PubMed
    Score: 0.226
  16. Are Medicinal Plants an Alternative Strategy to Combat COVID-19? Altern Ther Health Med. 2020 Aug; 26(S2):92-93.
    View in: PubMed
    Score: 0.224
  17. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak. Altern Ther Health Med. 2020 Aug; 26(S2):54-55.
    View in: PubMed
    Score: 0.224
  18. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol Ther. 2020 11; 33(6):e13871.
    View in: PubMed
    Score: 0.223
  19. Vesicular drug delivery systems as theranostics in COVID-19. Future Med Chem. 2020 09; 12(18):1607-1609.
    View in: PubMed
    Score: 0.222
  20. RAAS blockers in hypertension posing a higher risk toward the COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13501.
    View in: PubMed
    Score: 0.222
  21. COVID-19 transmission through host cell directed network of GPCR. Drug Dev Res. 2020 09; 81(6):647-649.
    View in: PubMed
    Score: 0.220
  22. Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract. J Photochem Photobiol B. 2019 Aug; 197:111531.
    View in: PubMed
    Score: 0.207
  23. A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia. Chem Biol Interact. 2019 Jun 01; 306:117-122.
    View in: PubMed
    Score: 0.205
  24. Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease. J Cell Physiol. 2019 08; 234(10):16703-16723.
    View in: PubMed
    Score: 0.204
  25. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems. Chem Biol Interact. 2019 Feb 01; 299:168-178.
    View in: PubMed
    Score: 0.200
  26. Targeting microRNAs using nanotechnology in pulmonary diseases. Panminerva Med. 2018 Dec; 60(4):230-231.
    View in: PubMed
    Score: 0.199
  27. Targeting bacterial biofilms in pulmonary diseases in pediatric population. Minerva Pediatr. 2019 Jun; 71(3):309-310.
    View in: PubMed
    Score: 0.198
  28. Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. Panminerva Med. 2018 Sep; 60(3):109-116.
    View in: PubMed
    Score: 0.196
  29. Nanotechnology in drug delivery gaining new perspectives in respiratory diseases. Panminerva Med. 2018 09; 60(3):135-136.
    View in: PubMed
    Score: 0.196
  30. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Biomed Pharmacother. 2018 Nov; 107:1218-1229.
    View in: PubMed
    Score: 0.196
  31. Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma. Colloids Surf B Biointerfaces. 2018 Dec 01; 172:51-59.
    View in: PubMed
    Score: 0.195
  32. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed Pharmacother. 2018 Oct; 106:707-713.
    View in: PubMed
    Score: 0.194
  33. 3D-printing: an emerging and a revolutionary technology in pharmaceuticals. Panminerva Med. 2018 Dec; 60(4):170-173.
    View in: PubMed
    Score: 0.193
  34. Novel drug delivery approaches in treating pulmonary fibrosis. Panminerva Med. 2018 Dec; 60(4):238-240.
    View in: PubMed
    Score: 0.189
  35. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med. 2018 Jun; 60(2):70-75.
    View in: PubMed
    Score: 0.188
  36. Advancements in nano drug delivery systems: a challenge for biofilms in respiratory diseases. Panminerva Med. 2018 03; 60(1):35-36.
    View in: PubMed
    Score: 0.188
  37. An Overview of Circular RNAs. Adv Exp Med Biol. 2018; 1087:3-14.
    View in: PubMed
    Score: 0.187
  38. Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer. Crit Rev Eukaryot Gene Expr. 2018; 28(3):217-221.
    View in: PubMed
    Score: 0.187
  39. Tumor suppressor role of miR-503. Panminerva Med. 2018 Mar; 60(1):17-24.
    View in: PubMed
    Score: 0.186
  40. Nephrotoxicity in Rats Exposed to Paracetamol: The Protective Role of Moralbosteroid, a Steroidal Glycoside. J Environ Pathol Toxicol Oncol. 2017; 36(2):113-119.
    View in: PubMed
    Score: 0.175
  41. Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders - A Mini Review. Pharm Nanotechnol. 2017; 5(4):250-254.
    View in: PubMed
    Score: 0.175
  42. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635.
    View in: PubMed
    Score: 0.060
  43. An Appraisal of the Current Scenario in Vaccine Research for COVID-19. Viruses. 2021 07 18; 13(7).
    View in: PubMed
    Score: 0.060
  44. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021 Aug 25; 345:109568.
    View in: PubMed
    Score: 0.060
  45. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021 09; 82(6):784-788.
    View in: PubMed
    Score: 0.058
  46. An overview of vaccine development for COVID-19. Ther Deliv. 2021 03; 12(3):235-244.
    View in: PubMed
    Score: 0.058
  47. Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug Dev Res. 2020 Jul 30.
    View in: PubMed
    Score: 0.056
  48. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. Pharm Nanotechnol. 2020; 8(4):323-353.
    View in: PubMed
    Score: 0.054
  49. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Chem Biol Interact. 2019 Aug 25; 309:108720.
    View in: PubMed
    Score: 0.052
  50. Recent update on anti-dengue drug discovery. Eur J Med Chem. 2019 Aug 15; 176:431-455.
    View in: PubMed
    Score: 0.051
  51. Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases. Chem Biol Interact. 2019 May 01; 304:10-19.
    View in: PubMed
    Score: 0.051
  52. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities. Biomed Pharmacother. 2019 Jan; 109:1785-1792.
    View in: PubMed
    Score: 0.050
  53. Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures. EXCLI J. 2017; 16:752-754.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.